264 related articles for article (PubMed ID: 17488182)
1. Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.
Critchley-Thorne RJ; Yan N; Nacu S; Weber J; Holmes SP; Lee PP
PLoS Med; 2007 May; 4(5):e176. PubMed ID: 17488182
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
[TBL] [Abstract][Full Text] [Related]
4. Impaired interferon signaling is a common immune defect in human cancer.
Critchley-Thorne RJ; Simons DL; Yan N; Miyahira AK; Dirbas FM; Johnson DL; Swetter SM; Carlson RW; Fisher GA; Koong A; Holmes S; Lee PP
Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9010-5. PubMed ID: 19451644
[TBL] [Abstract][Full Text] [Related]
5. Polyfunctional response by ImmTAC (IMCgp100) redirected CD8
Boudousquie C; Bossi G; Hurst JM; Rygiel KA; Jakobsen BK; Hassan NJ
Immunology; 2017 Nov; 152(3):425-438. PubMed ID: 28640942
[TBL] [Abstract][Full Text] [Related]
6. Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients.
Simons DL; Lee G; Kirkwood JM; Lee PP
J Transl Med; 2011 May; 9():52. PubMed ID: 21545749
[TBL] [Abstract][Full Text] [Related]
7. Impaired STAT phosphorylation in T cells from melanoma patients in response to IL-2: association with clinical stage.
Mortarini R; Vegetti C; Molla A; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Anichini A
Clin Cancer Res; 2009 Jun; 15(12):4085-94. PubMed ID: 19509154
[TBL] [Abstract][Full Text] [Related]
8. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
9. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ
Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma is induced in human peripheral blood immune cells in vitro by sodium stibogluconate/interleukin-2 and mediates its antitumor activity in vivo.
Fan K; Borden E; Yi T
J Interferon Cytokine Res; 2009 Aug; 29(8):451-60. PubMed ID: 19514839
[TBL] [Abstract][Full Text] [Related]
11. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
12. Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells.
Clifford JL; Yang X; Walch E; Wang M; Lippman SM
Mol Cancer Ther; 2003 May; 2(5):453-9. PubMed ID: 12748307
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS).
Tong S; Cinelli MA; El-Sayed NS; Huang H; Patel A; Silverman RB; Yang S
Sci Rep; 2022 Feb; 12(1):1701. PubMed ID: 35105915
[TBL] [Abstract][Full Text] [Related]
14. Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.
Sim GC; Wu S; Jin L; Hwu P; Radvanyi LG
Oncotarget; 2016 Jun; 7(24):36074-36091. PubMed ID: 27153543
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha.
Zimmerer JM; Lesinski GB; Ruppert AS; Radmacher MD; Noble C; Kendra K; Walker MJ; Carson WE
Clin Cancer Res; 2008 Sep; 14(18):5900-6. PubMed ID: 18794103
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
Verdegaal EM; Visser M; Ramwadhdoebé TH; van der Minne CE; van Steijn JA; Kapiteijn E; Haanen JB; van der Burg SH; Nortier JW; Osanto S
Cancer Immunol Immunother; 2011 Jul; 60(7):953-63. PubMed ID: 21431917
[TBL] [Abstract][Full Text] [Related]
17. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of CD4+ and CD8+ lymphocytes during chemoimmunotherapy in metastatic melanoma.
Hernberg MM; Hahka-Kemppinen MH; Pyrhönen SO
Melanoma Res; 2004 Dec; 14(6):493-500. PubMed ID: 15577320
[TBL] [Abstract][Full Text] [Related]
19. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
Tawfik DS; Cowan KR; Walsh AM; Hamilton WS; Goldman FD
Pediatr Allergy Immunol; 2012 Feb; 23(1):88-95. PubMed ID: 21265884
[TBL] [Abstract][Full Text] [Related]
20. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]